Biomaterials and Medical Devices

From a healthcare perspective, biomaterials can be characterized as materials that have some novel properties that make them suitable for immediate interaction with the living tissue without causing any adverse reactions to immune rejection. Biomaterials are natural or synthetic, alive or lifeless and typically consist of multiple components which interact with biological systems. Biomaterials have served mankind since ancient times but subsequent evolution has made them more flexible and increased their use. Biomaterials have changed the fields such as bioengineering and tissue engineering to establish strategies to combat diseases that endanger life. Similar principles and techniques are used to treat different illnesses, such as heart failure, fractures, deep skin injuries, etc. Work is being carried out to develop the current procedures and to invent new approaches. Biomaterials and Medical Devices interact indirectly with biological systems. Biomaterials can be inserted in medical applications to replace or restore the missing tissue.

•    Bioinspired materials
•    Biomedical devices
•    Biomedical devices
•    3D printing of organs and tissue
•    Biomimetic materials
•    Biomedical Applications of Nanoparticles
•    Biomaterials for Tissue Regeneration
•    Soft and Biological Matter
•    Radiotherapy
•    Body implants and prosthesis
•    Surfaces and interfaces of biomaterials
•    Hard and soft tissues
•    Friction, wear and fatigue in biomaterials
•    Biopolymers and bioplastics
•    Biomaterials imaging
•    Tissue engineering and regenerative medicine
•    Drug delivery systems

Market Analysis: The Biomaterials and Medical Devices market is set for robust growth from 2025 to 2038, driven by an aging population, chronic diseases, and healthcare tech advancements. The Biomaterials market alone is projected to reach $814.7 billion by 2035 (14.8% CAGR from 2025), fueled by demand for biocompatible materials in orthopedics, cardiovascular, dental, and regenerative medicine, alongside personalized medicine and 3D printing. Simultaneously, the broader Medical Devices market is expected to hit around $1,146.95 billion by 2034 (6% CAGR from 2025), boosted by AI/IoT integration, minimally invasive tools, and wearable devices, with wearables specifically reaching $66.9 billion by 2030 (10.1% CAGR).This expansion is further supportedby rising healthcares pending and evolving digital health solutions.For More Details: https://www.materialsscienceconference.com/tracks/biomaterials-and-medical-devices

Key Market Players :

Medtronic / Johnson & Johnson / Abbott Laboratories / Siemens Healthineers / Stryker Corporation / Boston Scientific / Becton Dickinson (BD) / Edwards Lifesciences / Dexcom / Mindray